Healthco Healthcare And Stock Current Valuation
| HCW Stock | 1.14 0.01 0.87% |
Valuation analysis of Healthco Healthcare and helps investors to measure Healthco Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Healthco Healthcare's Change In Cash is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 9 M in 2024, whereas Free Cash Flow is likely to drop slightly above 6.1 M in 2024. Fundamental drivers impacting Healthco Healthcare's valuation include:
Price Book 0.7069 | Enterprise Value 1.1 B | Enterprise Value Ebitda 31.8834 | Price Sales 8.8436 | Trailing PE 113.5 |
Overvalued
Today
Please note that Healthco Healthcare's price fluctuation is risky at this time. Calculation of the real value of Healthco Healthcare and is based on 3 months time horizon. Increasing Healthco Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Healthco Healthcare's intrinsic value may or may not be the same as its current market price of 1.14, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.14 | Real 1.03 | Hype 1.15 |
The intrinsic value of Healthco Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Healthco Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Healthco Healthcare and helps investors to forecast how Healthco stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healthco Healthcare more accurately as focusing exclusively on Healthco Healthcare's fundamentals will not take into account other important factors: Healthco Healthcare and Company Current Valuation Analysis
Healthco Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Healthco Healthcare Current Valuation | 1.11 B |
Most of Healthco Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthco Healthcare and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Healthco Healthcare and has a Current Valuation of 1.11 B. This is 92.71% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The current valuation for all Australia stocks is 93.34% higher than that of the company.
Healthco Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthco Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthco Healthcare could also be used in its relative valuation, which is a method of valuing Healthco Healthcare by comparing valuation metrics of similar companies.Healthco Healthcare is currently under evaluation in current valuation category among its peers.
Healthco Fundamentals
| Return On Equity | 0.0078 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.71 % | ||||
| Current Valuation | 1.11 B | ||||
| Shares Outstanding | 561 M | ||||
| Shares Owned By Insiders | 24.40 % | ||||
| Shares Owned By Institutions | 20.14 % | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 8.84 X | ||||
| Revenue | 73.8 M | ||||
| Gross Profit | 21.44 M | ||||
| EBITDA | 34.7 M | ||||
| Net Income | 6.9 M | ||||
| Total Debt | 481.1 M | ||||
| Book Value Per Share | 1.62 X | ||||
| Cash Flow From Operations | 6.4 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Target Price | 1.39 | ||||
| Beta | 0.79 | ||||
| Market Capitalization | 636.74 M | ||||
| Total Asset | 1.44 B | ||||
| Retained Earnings | (27 M) | ||||
| Working Capital | 12.1 M | ||||
| Annual Yield | 0.07 % | ||||
| Net Asset | 1.44 B | ||||
| Last Dividend Paid | 0.08 |
About Healthco Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healthco Healthcare and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthco Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthco Healthcare and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Healthco Stock Analysis
When running Healthco Healthcare's price analysis, check to measure Healthco Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthco Healthcare is operating at the current time. Most of Healthco Healthcare's value examination focuses on studying past and present price action to predict the probability of Healthco Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthco Healthcare's price. Additionally, you may evaluate how the addition of Healthco Healthcare to your portfolios can decrease your overall portfolio volatility.